{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T14:04:48Z","timestamp":1784383488807,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,18]]},"DOI":"10.7759\/cureus.112911","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:42:06Z","timestamp":1784382126000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Presentation of Dermatofibrosarcoma Protuberans (DFSP): The Role of Advanced Molecular Testing in Collagen Type I Alpha 1 Chain (COL1A1)-Negative Cases"],"prefix":"10.7759","author":[{"given":"Amanda","family":"Ruci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000300","article-title":"Incidence and survival of primary dermatofibrosarcoma protuberans in the United States","volume":"42 Suppl 1","author":"Kreicher KL","year":"2016","unstructured":"Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg. 2016, 42 Suppl 1:S24-31. 10.1097\/DSS.0000000000000300","journal-title":"Dermatol Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061752","article-title":"Dermatofibrosarcoma protuberans: update on the diagnosis and treatment","volume":"9","author":"Hao X","year":"2020","unstructured":"Hao X, Billings SD, Wu F, Stultz TW, Procop GW, Mirkin G, Vidimos AT. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment. J Clin Med. 2020, 9:1752. 10.3390\/jcm9061752","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/dermatopathology10010008","article-title":"Rare variants of dermatofibrosarcoma protuberans: clinical, histologic, and molecular features and diagnostic pitfalls","volume":"10","author":"Trinidad CM","year":"2023","unstructured":"Trinidad CM, Wangsiricharoen S, Prieto VG, Aung PP. Rare variants of dermatofibrosarcoma protuberans: clinical, histologic, and molecular features and diagnostic pitfalls. Dermatopathology (Basel). 2023, 10:54-62. 10.3390\/dermatopathology10010008","journal-title":"Dermatopathology (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115265","article-title":"Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024","volume":"218","author":"Saiag P","year":"2025","unstructured":"Saiag P, Lebbe C, Brochez L, et al.. Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline - update 2024. Eur J Cancer. 2025, 218:115265. 10.1016\/j.ejca.2025.115265","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001866","article-title":"Molecular characterization of dermatofibrosarcoma protuberans: the clinicopathologic significance of uncommon fusion gene rearrangements and their diagnostic importance in the exclusively subcutaneous and circumscribed lesions","volume":"46","author":"Lee PH","year":"2022","unstructured":"Lee PH, Huang SC, Wu PS, et al.. Molecular characterization of dermatofibrosarcoma protuberans: the clinicopathologic significance of uncommon fusion gene rearrangements and their diagnostic importance in the exclusively subcutaneous and circumscribed lesions. Am J Surg Pathol. 2022, 46:942-55. 10.1097\/PAS.0000000000001866","journal-title":"Am J Surg Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22663","article-title":"Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast","volume":"57","author":"Dickson BC","year":"2018","unstructured":"Dickson BC, Hornick JL, Fletcher CD, et al.. Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast. Genes Chromosomes Cancer. 2018, 57:437-45. 10.1002\/gcc.22663","journal-title":"Genes Chromosomes Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-025-04088-4","article-title":"Dermatofibrosarcoma protuberans with PDGFD rearrangements: a case series featuring a novel EMILIN1::PDGFD fusion and comprehensive literature review","volume":"487","author":"Sotiriou S","year":"2025","unstructured":"Sotiriou S, Chatzopoulos K, Charville GW, et al.. Dermatofibrosarcoma protuberans with PDGFD rearrangements: a case series featuring a novel EMILIN1::PDGFD fusion and comprehensive literature review. Virchows Arch. 2025, 487:349-61. 10.1007\/s00428-025-04088-4","journal-title":"Virchows Arch"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2023.04.018","article-title":"An update on selected cutaneous (myo) fibroblastic mesenchymal tumors","volume":"40","author":"Georgantzoglou N","year":"2023","unstructured":"Georgantzoglou N, Linos K. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors. Semin Diagn Pathol. 2023, 40:295-305. 10.1053\/j.semdp.2023.04.018","journal-title":"Semin Diagn Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11030430","article-title":"The rapidly expanding group of RB1-deleted soft tissue tumors: an updated review","volume":"11","author":"Libbrecht S","year":"2021","unstructured":"Libbrecht S, Van Dorpe J, Creytens D. The rapidly expanding group of RB1-deleted soft tissue tumors: an updated review. Diagnostics (Basel). 2021, 11:430. 10.3390\/diagnostics11030430","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/10668969231160261","article-title":"Platelet-derived growth factor-D fusion-positive dermatofibrosarcoma protuberans: case report of an atypical breast mass and literature review","volume":"31","author":"Chandler B","year":"2023","unstructured":"Chandler B, Jing F, David MP, Nazarullah A. Platelet-derived growth factor-D fusion-positive dermatofibrosarcoma protuberans: case report of an atypical breast mass and literature review. Int J Surg Pathol. 2023, 31:1610-7. 10.1177\/10668969231160261","journal-title":"Int J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100792","article-title":"Comprehensive clinicopathological and multiomics characterization of dermatofibrosarcoma protuberans revealed PDGFD fusion as distinct molecular subtype with better survival","volume":"38","author":"Yeung MC","year":"2025","unstructured":"Yeung MC, Fong T, Liu AP, et al.. Comprehensive clinicopathological and multiomics characterization of dermatofibrosarcoma protuberans revealed PDGFD fusion as distinct molecular subtype with better survival. Mod Pathol. 2025, 38:100792. 10.1016\/j.modpat.2025.100792","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100737","article-title":"Genomic profiling uncovers a broader spectrum of dermatofibrosarcoma protuberans: implications for diagnosis and therapy","volume":"38","author":"Smith SC","year":"2025","unstructured":"Smith SC, Sweeney K, Evans MG, et al.. Genomic profiling uncovers a broader spectrum of dermatofibrosarcoma protuberans: implications for diagnosis and therapy. Mod Pathol. 2025, 38:100737. 10.1016\/j.modpat.2025.100737","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003411","article-title":"Dermatofibrosarcoma protuberans recurrence after wide local excision versus Mohs micrographic surgery: a systematic review and meta-analysis","volume":"48","author":"Martin EC","year":"2022","unstructured":"Martin EC, Vyas KS, Batbold S, Erwin PJ, Brewer JD. Dermatofibrosarcoma protuberans recurrence after wide local excision versus Mohs micrographic surgery: a systematic review and meta-analysis. Dermatol Surg. 2022, 48:479-85. 10.1097\/DSS.0000000000003411","journal-title":"Dermatol Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.4940","article-title":"Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review","volume":"155","author":"Navarrete-Dechent C","year":"2019","unstructured":"Navarrete-Dechent C, Mori S, Barker CA, Dickson MA, Nehal KS. Imatinib treatment for locally advanced or metastatic dermatofibrosarcoma protuberans: a systematic review. JAMA Dermatol. 2019, 155:361-9. 10.1001\/jamadermatol.2018.4940","journal-title":"JAMA Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/507632-an-unusual-presentation-of-dermatofibrosarcoma-protuberans-dfsp-the-role-of-advanced-molecular-testing-in-collagen-type-i-alpha-1-chain-col1a1-negative-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:42:10Z","timestamp":1784382130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/507632-an-unusual-presentation-of-dermatofibrosarcoma-protuberans-dfsp-the-role-of-advanced-molecular-testing-in-collagen-type-i-alpha-1-chain-col1a1-negative-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.112911","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}